clinical trial · NCT05559931

Single and Repeat Doses of DMT in Healthy Subjects

$AGNPF →·phase1·active not recruiting·n = 60

StrokeN,N-DimethyltryptaminePlacebo

brief summary

This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjects, when given by intravenous (IV) infusion.

started

Jan 13, 2023

primary completion

Mar 1, 2026

completion

Mar 1, 2026

last updated

Jan 28, 2025

official title

A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of Ascending Single and Fixed Repeat Intravenous Doses of DMT in Healthy Subjects

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol